![Céline Breda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Céline Breda
Hoofd Techniek/Wetenschap/O&O bij
PHAXIAM THERAPEUTICS S.A.
Profiel
Céline Breda is currently the Chief Technical Officer at PHAXIAM Therapeutics SA since 2023.
Prior to this, she worked at Vivalis SA from 2005 to 2013 as Joint Managing Director & Head-Quality Control.
She also worked as Director-Industrial Operations at Pherecydes Pharma SA.
Actieve functies van Céline Breda
| Bedrijven | Functie | Begin |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Hoofd Techniek/Wetenschap/O&O | 23-06-2023 |
Eerdere bekende functies van Céline Breda
| Bedrijven | Functie | Einde |
|---|---|---|
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Manufactures human and animal vaccines | President | 20-07-2010 |
| PHERECYDES PHARMA | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Manufactures human and animal vaccines | Health Technology |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
PHAXIAM Therapeutics SA
 PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
